Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of MI078 capsules for postpartum depression
ChiCTR2600132204Phase 3Not yet recruiting
- Sponsor
- Beijing Anding Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of MI078 in postpartum depression (PPD) (2 arms), sponsored by Beijing Anding Hospital. Primary endpoint: Change in HAMD-17 total score from baseline on day 4. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
MI078
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2600132204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132204.